Single molecule counting (SMC®) technology enables precise measurement of molecules at levels previously undetectable, down to the femtogram/mL levels, allowing researchers to identify new biomarkers, or assist in therapeutic development with an improved view of efficacy, safety, and time course studies. When time and resources are limited, we offer a comprehensive portfolio of custom services supported by a scientific team with core expertise in SMC® technology.
Learn how our team will partner with you to develop a project specific to your requirements, whether that is fit-for-purpose sample testing, biomarker analysis using our current SMC® immunoassays, or development and manufacture of an immunoassay for your novel target of interest. See how we work with our clients to define and tailor a customized project plan that includes milestone driven tasks, collaborative data review, and progress reports. Whether your focus is to expedite your clinical research or to transfer a method to a CRO, our services can help you accelerate programs from discovery into clinical trials.
For Research Use Only. Not For Use In Diagnostic Procedures.
Speaker
Sarah Hamren
Merck
Former Head of Custom Assays & Sample Testing Group
Sarah Hamren was the former head of the SMC® Custom Assay and Sample Testing group until 2021. She has over 30 years of experience in biopharma research and development and her past experience includes work at Chiron Corporation, Bayer Corporation’s Biotechnology division, Tethys Bioscience, and Singulex® Inc. before joining us. She is co-author on 15 peer-reviewed publications and holds 2 U.S. patents. Sarah’s experience effectively partnering with a broad array of clients has culminated in hundreds of successful biomarker assay development projects.
Protein biology
- Protein quantitation
Dauer:45min
Sprache:English
Sitzung 1:vorgestellt May 23, 2018
Um weiterzulesen, melden Sie sich bitte an oder erstellen ein Konto.
Sie haben kein Konto?